Dark Horse Consulting Expands into China with New Shanghai Office
Dark Horse Consulting Group (DHCG) has officially opened its Shanghai office with a ribbon-cutting ceremony. The event marked the formation of Dark Horse Consulting China, which aims to help biotherapeutic developers leverage China's advanced CDMO and CRO infrastructure.
The company announced the launch of Dark Horse Consulting China in August 2026, led by Kang Liu, Ph.D., Senior Director, Head of China. Anthony Davies, Ph.D., Founder and CEO of DHCG, emphasized that biotech is a truly global industry, and China is now a core consideration for western developers.
Dark Horse Consulting China will guide clients through every stage of the IIT process, from assessing strategic fit to CMC planning and supply chain management. The company aims to make the opportunity to generate meaningful clinical data in China navigable for its clients.